PRK Partners advised Affimed GmbH on the deal. Affimed GmbH, a clinical-stage immuno-oncology company, completed a successful divestment of AbCheck s.r.o., a Czech biotech company focusing on...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here